Contact A Lawyer
Near You

Contact us today for a complimentary consultation with a qualified attorney near you.

Celebrex Recall

In a report that was issued on December 17, 2004, Pfizer stated that they have no plans to issue a Celebrex recall despite medical evidence showing that patients who take this prescription painkiller are at an increased risk of suffering serious cardiovascular side effects. Pfizer, one of the largest pharmaceutical companies in the world, has enjoyed an annual revenue of almost three billion dollars from Celebrex sales in the US since this prescription painkiller was first approved by the FDA in 1999. Celebrex, and other COX-2 selective non-steroidal anti inflammatory drugs (NSAIDs), are prescribed to treat the severe pain associated with arthritis and primary dysmenorrhea (severe menstrual cramps). Celebrex alone has been prescribed to at least 27 million Americans.

Many experts claim that a Celebrex recall many be imminent, in light of recent medical evidence regarding Celebrex that closely mimic the findings of Vioxx drug trials. Talk of a Celebrex recall comes just two months after a similar drug, called Vioxx, was pulled from the shelves because of the severe adverse cardiovascular risks associated with this COX-2 selective drug use. On September 30, 2004 Vioxx was pulled from the market after an internal study revealed that patients who had taken Vioxx for eighteen months were twice as likely to suffer heart attack or stroke as were patients in the control group. Since this recall, the cardiovascular safety of all COX-2 selective drugs has come under heavy scrutiny. Both a Celebrex recall and a Bextra recall have been discussed as possibilities in the event that safety studies on these drugs produce similar findings.

Many pundits, including medical professionals and consumer advocacy groups, are calling for a Celebrex recall because studies indicate that taking Celebrex might be even more injurious to cardiovascular health that Vioxx use. A study conducted by the National Cancer Institute was originally designed to test the effects of Celebrex in treatment of cancer. This clinical trial was cut short after preliminary findings showed that patients taking between 400 and 800 milligrams of Celebrex were two and a half times more likely to suffer from heart attack or cardiovascular stroke than were patients in the control group.

On December 17, 2004, Pfizer stated that they will take immediate measures to understand the results of this clinical trial and communicate their findings worldwide, but that they do not intend on issuing a Celebrex recall. The pharmaceutical giant has been eager to point out that another long term study conducted on Celebrex safety has not found an increase in cardiovascular risks for patients taking Celebrex.

If you are currently taking Celebrex and are concerned about the risk of serious side effects, it is important to speak with your doctor before making any changes to your treatment. Your doctor will be able to factor this new information, as well as information about other known risks, into any decision about changing your treatment regiment. If you have suffered injuries as a result of taking Celebrex, you may also wish to contact a lawyer who can advise you of your legal rights and options in a case to recover you losses.

If you have taken Celebrex arthritis drug and have suffered adverse reactions because of it, please contact us to speak with a Celebrex Recall lawyer for more information.

Contact a Celebrex Recall Lawyer

More Celebrex Resources

MedLine Plus Drug Information - Guide to prescription and over-the-counter medications provided by the United States Pharmacopeia.

Celebrex - A source of information about relief from arthritis pain including Osteoarthritis and Rheumatoid Arthritis.

CELEBREX IN THE NEWS